panitumumab,bevacizumab
takeda,roche,amgen
['lcsm,(-blcsm)', 'nsclc', 'paradigm', 'sclc']
 discussing the future paradigm for the treatment of nsclc patients with egfr mutation #esmo22 #lcsm 
Medical Oncologist